{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T01:03:38Z","timestamp":1771031018228,"version":"3.50.1"},"reference-count":15,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.urolonc.2017.08.012","type":"journal-article","created":{"date-parts":[[2017,9,12]],"date-time":"2017-09-12T07:18:10Z","timestamp":1505200690000},"page":"675.e1-675.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Sialyl-Tn identifies muscle-invasive bladder cancer basal and luminal subtypes facing decreased survival, being expressed by circulating tumor cells and metastases"],"prefix":"10.1016","volume":"35","author":[{"given":"Lu\u00eds","family":"Lima","sequence":"first","affiliation":[]},{"given":"Manuel","family":"Neves","sequence":"additional","affiliation":[]},{"given":"Marta I.","family":"Oliveira","sequence":"additional","affiliation":[]},{"given":"Lorena","family":"Dieguez","sequence":"additional","affiliation":[]},{"given":"Rui","family":"Freitas","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3015-9675","authenticated-orcid":false,"given":"Rita","family":"Azevedo","sequence":"additional","affiliation":[]},{"given":"Cristiana","family":"Gaiteiro","sequence":"additional","affiliation":[]},{"given":"Janine","family":"Soares","sequence":"additional","affiliation":[]},{"given":"Dylan","family":"Ferreira","sequence":"additional","affiliation":[]},{"given":"Andreia","family":"Peixoto","sequence":"additional","affiliation":[]},{"given":"Elisabete","family":"Fernandes","sequence":"additional","affiliation":[]},{"given":"Diana","family":"Montezuma","sequence":"additional","affiliation":[]},{"given":"Ana","family":"Tavares","sequence":"additional","affiliation":[]},{"given":"Ricardo","family":"Ribeiro","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2014-7830","authenticated-orcid":false,"given":"Ana","family":"Castro","sequence":"additional","affiliation":[]},{"given":"Manuel","family":"Oliveira","sequence":"additional","affiliation":[]},{"given":"Avelino","family":"Fraga","sequence":"additional","affiliation":[]},{"given":"Celso A.","family":"Reis","sequence":"additional","affiliation":[]},{"given":"L\u00facio Lara","family":"Santos","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9 Alexandre","family":"Ferreira","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2017.08.012_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000370165","article-title":"Bladder tumor heterogeneity: the impact on clinical treatment","volume":"95","author":"Chen","year":"2015","journal-title":"Urol Int"},{"key":"10.1016\/j.urolonc.2017.08.012_bib2","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1073\/pnas.1120605109","article-title":"Three differentiation states risk-stratify bladder cancer into distinct subtypes","volume":"109","author":"Volkmer","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.urolonc.2017.08.012_bib3","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1073\/pnas.1318376111","article-title":"Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology","volume":"111","author":"Damrauer","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.urolonc.2017.08.012_bib4","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ccr.2014.01.009","article-title":"Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy","volume":"25","author":"Choi","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.urolonc.2017.08.012_bib5","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.molonc.2013.03.001","article-title":"Overexpression of tumour-associated carbohydrate antigen sialyl-Tn in advanced bladder tumours","volume":"7","author":"Ferreira","year":"2013","journal-title":"Mol Oncol"},{"key":"10.1016\/j.urolonc.2017.08.012_bib6","doi-asserted-by":"crossref","first-page":"e0141253","DOI":"10.1371\/journal.pone.0141253","article-title":"Abnormal protein glycosylation and activated PI3K\/Akt\/mTOR pathway: role in bladder cancer prognosis and targeted therapeutics","volume":"10","author":"Costa","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.urolonc.2017.08.012_bib7","first-page":"735","article-title":"Patient-derived sialyl-Tn-positive invasive bladder cancer xenografts in nude mice: an exploratory model study","volume":"34","author":"Bernardo","year":"2014","journal-title":"Anticancer Res"},{"key":"10.1016\/j.urolonc.2017.08.012_bib8","doi-asserted-by":"crossref","first-page":"63138","DOI":"10.18632\/oncotarget.11257","article-title":"Hypoxia enhances the malignant nature of bladder cancer cells and concomitantly antagonizes protein O-glycosylation extension","volume":"7","author":"Peixoto","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.urolonc.2017.08.012_bib9","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/1878-0261.12035","article-title":"Targeted O-glycoproteomics explored increased sialylation and identified MUC16 as a poor prognosis biomarker in advanced-stage bladder tumours","volume":"11","author":"Cotton","year":"2017","journal-title":"Mol Oncol"},{"key":"10.1016\/j.urolonc.2017.08.012_bib10","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.molonc.2014.02.008","article-title":"Sialyl Tn-expressing bladder cancer cells induce a tolerogenic phenotype in innate and adaptive immune cells","volume":"8","author":"Carrascal","year":"2014","journal-title":"Mol Oncol"},{"key":"10.1016\/j.urolonc.2017.08.012_bib11","unstructured":"Di\u00e9guez L, Samy S, Oliveira M, Gaspar J. Microscale cell filter. Patent: PCT\/EP2016\/078406. November 22, 2016."},{"key":"10.1016\/j.urolonc.2017.08.012_bib12","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nrc3820","article-title":"Challenges in circulating tumour cell research","volume":"14","author":"Alix-Panabieres","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.urolonc.2017.08.012_bib13","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1126\/science.1235226","article-title":"Cancer. Circulating tumor cells","volume":"341","author":"Plaks","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.urolonc.2017.08.012_bib14","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.canlet.2006.08.010","article-title":"Biological significance of cancer-associated sialyl-Tn antigen: modulation of malignant phenotype in gastric carcinoma cells","volume":"249","author":"Pinho","year":"2007","journal-title":"Cancer Lett"},{"key":"10.1016\/j.urolonc.2017.08.012_bib15","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1093\/glycob\/cwj033","article-title":"ST6GalNAc I expression in MDA-MB-231 breast cancer cells greatly modifies their O-glycosylation pattern and enhances their tumourigenicity","volume":"16","author":"Julien","year":"2006","journal-title":"Glycobiology"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143917304222?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143917304222?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:12:15Z","timestamp":1761041535000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143917304222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":15,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S1078143917304222"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2017.08.012","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sialyl-Tn identifies muscle-invasive bladder cancer basal and luminal subtypes facing decreased survival, being expressed by circulating tumor cells and metastases","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2017.08.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}